Acidic conditions ameliorate both adenosine triphosphate depletion and the development of hyperpermeability in cultured Caco-2BBe enterocytic monolayers subjected to metabolic inhibition

Surgery
N UnnoM P Fink

Abstract

We recently reported that moderate degrees of adenosine triphosphate (ATP) depletion induced by chronic glycolytic inhibition or hypoxia increase the permeability of Caco-2BBe enterocytic monolayers. Interestingly, the development of lactic acidosis induced by anaerobic glycolysis ameliorates the development of hyperpermeability caused by chronic ATP depletion. We sought to further elucidate the mechanism(s) responsible for the apparent protection against epithelial hyperpermeability afforded by mild acidosis under conditions of metabolic inhibition. Caco-2BBe monolayers growing on permeable supports in bicameral chambers were incubated with 2-deoxyglucose (2DOG) in a glucose-free (Glu-) environment to inhibit glycolysis. Permeability was determined by measuring the transepithelial flux of fluorescein sulfonic acid. Concentrations of intracellular calcium [Ca2+]i were determined fluorometrically by using fura-2. When extracellular pH (pH0) was maintained at 7.4 or 5.5, incubation of monolayers for 24 hours with Glu-/2DOG increased permeability and depleted intracellular ATP levels. However, keeping pH0 at 7.0 to 6.0 ameliorated both the development of hyperpermeability and the depletion of ATP induced by Glu-/2DOG. These protec...Continue Reading

References

Jan 1, 1992·The American Journal of Physiology·J A McRoberts, N E Riley
Dec 1, 1992·The American Journal of Physiology·M W Peterson, M E Walter
May 1, 1991·Analytical Biochemistry·J E WhitakerF G Prendergast
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K S LeeG Lynch
Jan 31, 1991·Biochemical and Biophysical Research Communications·D C HarrisonB Herman
Jul 1, 1991·Physiological Reviews·D E Croall, G N DeMartino
Jul 1, 1990·The American Journal of Physiology·M W Peterson, D Gruenhaupt
Apr 1, 1990·The Journal of Clinical Investigation·J A McRobertsH Kang
Apr 1, 1990·American Journal of Respiratory Cell and Molecular Biology·M WinterD M Shasby
Feb 1, 1989·The Journal of Clinical Investigation·J L Madara, J Stafford
Oct 1, 1988·The Journal of Clinical Investigation·C E McCoyJ H Schwartz
Dec 15, 1988·The Biochemical Journal·K S Kan, R Coleman
Oct 1, 1986·British Medical Bulletin·D G Nicholls
Sep 1, 1988·The Journal of Clinical Investigation·V D NguyenH D Humes
Dec 1, 1987·The American Journal of Physiology·J L MadaraS Carlson
Sep 17, 1984·Biochemical and Biophysical Research Communications·W H Huang, A Askari
Dec 1, 1980·The Journal of Cell Biology·A Martinez-PalomoM Cereijido
Oct 1, 1982·The Journal of Cell Biology·T J RinkT Pozzan
Jan 27, 1995·Cell·D E Clapham
May 1, 1997·The American Journal of Physiology·M J MenconiM P Fink

❮ Previous
Next ❯

Citations

Jul 3, 1998·Gastroenterology Clinics of North America·N Unno, M P Fink
May 12, 2000·Critical Care Medicine·D J BertgesR L Delude
Mar 17, 1999·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·L GisselssonB K Siesjö
Jul 29, 2003·Current Opinion in Critical Care·Jacques Levraut, Dominique Grimaud
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·M HayashiS Awazu
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·T L MoserS V Pizzo
Apr 13, 2010·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Eun-Ju LeeMi-Kyung Sung
Jun 6, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Cyril VidauLuc P Belzunces
Jun 19, 2015·Pediatric Research·Bettina Bidmon-FliegenschneeKlaus Kratochwill
Apr 26, 2006·Journal of Clinical Pharmacy and Therapeutics·W C W Wong, J H S You
Dec 20, 2002·American Journal of Physiology. Cell Physiology·Tom S LiuEugene B Chang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.